Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Biosciences Laboratory
Giorgia Marisi has not added Biography.
If you are Giorgia Marisi and would like to personalize this page please email our Author Liaison for assistance.
Discrepancies between VEGF -1154 G>A polymorphism analysis performed in peripheral blood samples and FFPE tissue.
International journal of molecular sciences Jul, 2014 | Pubmed ID: 25079441
eNOS polymorphisms as predictors of efficacy of bevacizumab-based chemotherapy in metastatic colorectal cancer: data from a randomized clinical trial.
Journal of translational medicine Aug, 2015 | Pubmed ID: 26259598
Right- vs. Left-Sided Metastatic Colorectal Cancer: Differences in Tumor Biology and Bevacizumab Efficacy.
International journal of molecular sciences Jun, 2017 | Pubmed ID: 28598398
Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer.
International journal of molecular sciences Jan, 2018 | Pubmed ID: 29361687
Heterogeneity in Colorectal Cancer: A Challenge for Personalized Medicine?
International journal of molecular sciences Nov, 2018 | Pubmed ID: 30477151
IL-8 and thrombospondin-1 as prognostic markers in patients with metastatic colorectal cancer receiving bevacizumab.
Cancer management and research , 2018 | Pubmed ID: 30532588
Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer.
Journal of clinical medicine Jan, 2019 | Pubmed ID: 30678026
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS
Laura Mercatali1,
Patrizia Serra2,
Giacomo Miserocchi1,
Chiara Spadazzi1,
Chiara Liverani1,
Alessandro De Vita1,
Giorgia Marisi3,
Alberto Bongiovanni1,
Federica Recine1,
Akwilina Pangan4,
Nestory Masalu4,
Toni Ibrahim1,
Dino Amadori1
1Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy,
2Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy,
3Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy,
4Department of Oncology, Bugando Medical Center, Mwanza, Tanzania
Matteo Canale1,
Giorgia Marisi1,
Alessandro Passardi2,
Emanuela Scarpi3,
Paola Ulivi1
1Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS,
2Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS,
3Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.